FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

10 letters match. Newest first.

  1. Chirp Innovations, LLC

    FDA warned Chirp Innovations over quality-system gaps, missing adverse-event reporting procedures, and unapproved marketing of its Halo muscle stimulator for menstrual pain.

    High risk
  2. Lion Street Medical, d/b/a Pensar Medical LLC

    FDA warns Pensar Medical over unreported wound-therapy injuries and missing device reporting procedures.

    High risk
  3. Insung Medical Co. Ltd.

    FDA warns Insung Medical over unreported ANKOR Endobronchial Tube malfunction and inadequate MDR procedures.

    High risk
  4. O3UV, LLC

    FDA warns O3UV that its Champion and EBOO ozone/UV blood devices are unapproved, misbranded, and made without required quality controls.

    High risk
  5. Aju Pharm Co., Ltd.

    FDA warns Aju Pharm over unvalidated Fixone suture anchors and multiple quality-system failures.

    High risk
  6. Pinnacle Labs of Tennessee, LLC dba Pinnacle BioLabs

    Pinnacle BioLabs sells a fecal blood test as a colon cancer screening test without FDA clearance and lacks complaint, CAPA and MDR procedures.

    High risk
  7. Fresenius Kabi AG

    FDA warned Fresenius Kabi about quality and reporting failures for its Ivenix Infusion System.

    High risk
  8. Neitz Instruments Company Ltd.

    FDA warns Neitz Instruments its ophthalmoscope is misbranded because medical device reporting procedures are inadequate.

    Medium
  9. Aizu Olympus Co., Ltd.

    Aizu Olympus failed to validate endoscope designs and manufacturing processes and lacked MDR procedures, FDA says.

    High risk
  10. CellEra LLC

    CellEra LLC's sterile silver wound dressings have repeated quality-system violations and uncleared labeling claims, FDA says.

    High risk